These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 3606334

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Is fibrocystic disease precancerous?].
    De León Antoni E.
    Bol Asoc Med P R; 1989 Nov; 81(11):451-4. PubMed ID: 2690835
    [Abstract] [Full Text] [Related]

  • 4. [Histology, normal borderline forms and pathologic proliferation patterns of the breast].
    Holzner JH.
    Verh Dtsch Ges Pathol; 1985 Nov; 69():26-50. PubMed ID: 4096107
    [No Abstract] [Full Text] [Related]

  • 5. [Pathology, systematic aspects and classification of benign breast diseases].
    Bässler R, Kind M.
    Gynakologe; 1989 Aug; 22(4):216-25. PubMed ID: 2676756
    [No Abstract] [Full Text] [Related]

  • 6. [Benign and premalignant breast lesions--clinico-pathological correlation].
    Afek A, Shibi R, Kopolovitz G.
    Harefuah; 1997 Nov 02; 133(9):375-8. PubMed ID: 9418343
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Is fibrocystic disease of the breast precancerous?
    Godfrey SE.
    Arch Pathol Lab Med; 1986 Nov 02; 110(11):991. PubMed ID: 3778132
    [No Abstract] [Full Text] [Related]

  • 13. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.
    Masood S.
    Clin Lab Med; 2005 Dec 02; 25(4):713-31, vi. PubMed ID: 16308088
    [Abstract] [Full Text] [Related]

  • 14. [Significance of proliferative breast lesions around breast cancers].
    Moriya T, Manabe T, Sakurai T, Sakamoto K.
    Gan To Kagaku Ryoho; 1995 Apr 02; 22 Suppl 1():42-5. PubMed ID: 7747991
    [Abstract] [Full Text] [Related]

  • 15. [Variants of the morphogenesis of breast cancer].
    Danilenko VI.
    Vopr Onkol; 1984 Apr 02; 30(6):74-8. PubMed ID: 6741009
    [Abstract] [Full Text] [Related]

  • 16. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
    Shirley SE.
    West Indian Med J; 1999 Dec 02; 48(4):173-8. PubMed ID: 10639833
    [Abstract] [Full Text] [Related]

  • 17. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast.
    Sahoo S, Recant WM.
    Breast J; 2005 Dec 02; 11(2):140-2. PubMed ID: 15730461
    [Abstract] [Full Text] [Related]

  • 18. Benign breast diseases: risk factor or precancerous state?
    Gerber M.
    Eur J Cancer Prev; 1993 Nov 02; 2 Suppl 3():113-8. PubMed ID: 8298440
    [No Abstract] [Full Text] [Related]

  • 19. Bilateral synchronous breast cancer. A clinical dilemma.
    Guraya SY, Khairy GA.
    Saudi Med J; 2004 Dec 02; 25(12):2024-5. PubMed ID: 15711694
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.